Psychiatric disorders in patients with Behget's disease

被引:13
作者
Dursun, Recep
Uguz, Faruk
Kaya, Nazmiye
Cilli, Ali Savas
Endogru, Huseyin
机构
[1] Baskent Univ, Konya Res & Training Hosp, Dept Dermatol, Konya, Turkey
[2] Selcuk Univ, Meram Fac Med, Dept Psychiat, Konya, Turkey
[3] Selcuk Univ, Meram Fac Med, Dept Dermatol, Konya, Turkey
关键词
Behcet's disease; psychiatric disorders; anxiety; depression; NATIONAL-COMORBIDITY-SURVEY; NECROSIS-FACTOR-ALPHA; BEHCETS-DISEASE; MAJOR DEPRESSION; UNITED-STATES; MENTAL-DISORDERS; PREVALENCE; ANXIETY; INTERLEUKIN-6; LIFETIME;
D O I
10.1080/13651500600811438
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective. In this study, we aimed to investigate current prevalence and related clinical factors of psychiatric disorders in Behcet patients. Methods. Seventy-three outpatients who applied to a Behcet clinic and whose diagnosis was Behcet's disease according to criteria of the International Study Group for Behcet's disease were recruited in this study. Psychiatric diagnoses were assessed with The Structured Clinical Interview for DSM-IV/Clinical Version (SCID-I/CV). Results. Thirty patients (41.1%) reported at least one current psychiatric disorder. Major depression (17.8%) was the most frequent psychiatric disorder. Specific phobia (16.4%), generalized anxiety disorder (15.1%) and social phobia (9.6%) were other frequent disorders. Prevalence rates of any psychiatric and anxiety disorder were significantly higher in females than males. There was no significant relationship between psychiatric morbidity and clinical characteristics of Behcet's disease. Conclusion. Our study suggests that Behcet patients have high prevalence of psychiatric disorders. Therefore, psychiatric evaluation should be performed in all patients with Behcet's disease.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 34 条
[1]  
Akdeniz N, 2004, ANN ACAD MED SINGAP, V33, P596
[2]  
Behçet H, 1937, DERMATOL WOCHENSCHR, V105, P1152
[3]  
BLAZER DG, 1994, AM J PSYCHIAT, V151, P979
[4]  
BORSON S, 1982, AM J PSYCHIAT, V139, P1348
[5]   Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α:: Central monoamine, corticosterone, and behavioral variations [J].
Brebner, K ;
Hayley, S ;
Zacharko, R ;
Merali, Z ;
Anisman, H .
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (06) :566-580
[6]   Depression, anxiety levels and general psychological profile in Behcet's disease [J].
Calikoglu, E ;
Onder, M ;
Cosar, B ;
Candansayar, S .
DERMATOLOGY, 2001, 203 (03) :238-240
[7]  
CANINO GJ, 1987, ARCH GEN PSYCHIAT, V44, P727
[8]  
Corapcioglu A, 1999, DSM IV EKSEN BOZUKLU
[9]   Cytokine inhibitors:: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behcet's disease [J].
Düzgün, N ;
Ayaslioglu, E ;
Tutkak, H ;
Aydintug, OT .
RHEUMATOLOGY INTERNATIONAL, 2005, 25 (01) :1-5
[10]   PSYCHIATRIC ASPECTS OF BEHCETS SYNDROME [J].
EPSTEIN, RS ;
CUMMINGS, NA ;
SHERWOOD, EB ;
BERGSMA, DR .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1970, 14 (02) :161-&